---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-121675"
form_type: "8-K"
ticker: "BGMS"
cik: "0001130166"
company_name: "Bio Green Med Solution, Inc."
filed_at: "2023-11-28T23:59:59+00:00"
generated_at: "2026-06-07T20:46:36.682031+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Cyclacel receives Nasdaq notice for late Q3 10-Q filing; 60 days to submit compliance plan

## Summary
- Notice received Nov 21, 2023 for failure to timely file Quarterly Report for period ended Sep 30, 2023.
- Company has 60 calendar days (to Jan 20, 2024) to submit a plan to regain compliance.
- If accepted, Nasdaq may grant up to 180 days (to May 20, 2024) to file the overdue report.
- No immediate effect on listing, but no assurance compliance can be regained.
- Common stock (CYCC) and preferred stock (CYCCP) listed on Nasdaq Capital Market.

## SEC filing metadata
- accession: 0001104659-23-121675
- form_type: 8-K
- ticker: BGMS
- cik: 0001130166
- company_name: Bio Green Med Solution, Inc.
- filed_at: 2023-11-28T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1130166/000110465923121675/0001104659-23-121675-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1130166/000110465923121675/tm2331442d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-121675
- JSON: https://secwatch.observer/filing/0001104659-23-121675.json
- Plain text: https://secwatch.observer/filing/0001104659-23-121675.txt

## Key facts
- Listing & Compliance Notices
  Bio Green Med Solution, Inc. received a nasdaq noncompliance notice notice regarding late filing.
  - Exchange: nasdaq
  - Notice: noncompliance notice
  - Deficiency: late filing
  source text: November 21, 2023, Cyclacel Pharmaceuticals, Inc. (the “Company”) received a written notice (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with Nasdaq’s continued listing standards because the Company did not timely file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2023 (the “Quarterly Report”). Under Nasdaq rules, the Company now has 60 calendar days (or until January 20, 2024) to submit a plan to regain compliance. If Nasdaq accepts the Company’s plan, Nasdaq can grant an exception of up to 180 calendar da
  evidence_url: https://www.sec.gov/Archives/edgar/data/1130166/000110465923121675/0001104659-23-121675-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.